Klox Technologies Limited

Fb Maria Srl

Vetoquinol S.a.

Fle International S.r.l.

Lise Hébert

Remigio Piergallini

Nikolaos Loupis

Francesco Bellini

Andrea Spaterna

David Ohayon

Marco Marchetti

Giovanni Scapagnini

Andreas Nikolis

Alberto Salvaggio

Angela Palumbo Piccionello

Cecilia Vullo

The present disclosure generally relates to compounds comprising homotaurine that may be used in improving the general mental condition and/or general brain function of a non-human animal, and for the prophylaxis of chronic, aging-related mental deterioration in non-human animals. In addition, the present disclosure generally relates to compositions comprising homotaurine that may be used in determining whether a candidate veterinary compound and/or a candidate formulation can improve general mental condition and/or general brain function of animals and for the prophylaxis of chronic, aging-related mental deterioration in non-human animals.

Homotaurine-enriched compositions and methods of use for animal health

The present technology generally relates to a method for modulating in situ production of energy by a biological tissue. The method comprises stimulating the biological tissue by exposing the biological tissue to a photostimulated biophotonic composition for a time sufficient to initiate the production of energy by the biological tissue.

Biophotonic methods for increasing in situ energy production and energy emission in biological cells and tissues

The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for use in the treatment of skin and soft tissue wounds that have either or both non-resistant and resistant infections.

Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections

The present disclosure relates to a phototherapy device that can deliver light to tissues to activate photoactive agents that have been applied to the tissues or that are included within a fiber optic tip member of the device which may be coupled to a light source using a sleeve. The present disclosure also relates to methods of phototherapy using the phototherapy device such as anti-bactericidal treatment, anti-fungal treatment, anti-parasitic treatment, anti-viral treatment.

Phototherapy devices and methods

The present disclosure relates to methods for stimulating collagen synthesis, cosmetic enhancement of soft tissue and/or inhibiting or treating scarring comprising administering a composition to an area to be treated within a soft tissue, wherein the composition comprises a tissue filler medium and a fluorophore; and illuminating the area with light having a wavelength which can be absorbed by the fluorophore.

Tissue filler compositions and methods of use

There is provided an applicator cartridge for delivery of a photoactivatable composition to a treatment site, having an applicator head and a reservoir adapted to receive the composition, which may be used with a photodynamic therapy device comprising an illuminating member. Methods of using the applicator cartridge and the device are also provided.

Growing community of inventors

Montreal, Canada

Lise Hébert